Telomir Pharmaceuticals, Inc. (TELO)
0.88
+0.10
(+12.81%)
USD |
NASDAQ |
Nov 06, 10:37
Telomir Pharmaceuticals Total Assets (Quarterly) : 5.366M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.366M |
| March 31, 2026 | 5.790M |
| December 31, 2025 | 7.341M |
| September 30, 2025 | 7.402M |
| June 30, 2025 | 0.8296M |
| March 31, 2025 | 0.4912M |
| December 31, 2024 | 1.324M |
| September 30, 2024 | 1.042M |
| Date | Value |
|---|---|
| June 30, 2024 | 2.102M |
| March 31, 2024 | 3.503M |
| December 31, 2023 | 4.774M |
| September 30, 2023 | 5.319M |
| June 30, 2023 | 5.922M |
| March 31, 2023 | |
| December 31, 2022 | 0.0487M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.3324M |
| Shareholders Equity (Quarterly) | 5.034M |
| Debt to Equity Ratio | 0.0271 |
| Current Ratio | 16.14 |
| Net Debt Paydown Yield | -0.03% |